| Sequential SPECT and Optical Imaging of Experimental Models of Prostate Cancer with a Dual Modality Inhibitor of the Prostate-Specific Membrane Antigen | journal | August 2011 | 
    | Iterative In Situ Click Chemistry Creates Antibody-like Protein-Capture Agents | journal | June 2009 | 
    | Bio-Inspired Design and Potential Biomedical Applications of a Novel Class of High-Affinity Peptides | journal | January 2012 | 
    | Correspondence Re: Ghosh A and Heston WDW. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. J Cell Biochem 91:528-539, 2004 | journal | October 2004 | 
    | High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer | journal | August 2010 | 
    | Construction of High-Complexity Combinatorial Phage Display Peptide Libraries | journal | February 2001 | 
    | A low molecular weight PSMA-based fluorescent imaging agent for cancer | journal | December 2009 | 
    | Rapid identification of improved protein ligands using peptoid microarrays | journal | July 2009 | 
    | Modulation of nuclear internalization of Tat peptides by fluorescent dyes and receptor-avid peptides | journal | April 2007 | 
    | Re: Screening for Prostate Cancer with Prostate-Specific Antigen Testing: American Society of Clinical Oncology Provisional Clinical Opinion | journal | February 2013 | 
    | Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM) | journal | February 2004 | 
    | Virus–Polymer Hybrid Nanowires Tailored to Detect Prostate-Specific Membrane Antigen | journal | March 2012 | 
    | Radiohalogenated Prostate-Specific Membrane Antigen (PSMA)-Based Ureas as Imaging Agents for Prostate Cancer | journal | December 2008 | 
    | PSMA mimotope isolated from phage displayed peptide library can induce PSMA specific immune response | journal | December 1999 | 
    | Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer | journal | February 2006 | 
    | Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase | journal | April 2005 | 
    | Engineered antibody Fc variants with enhanced effector function | journal | March 2006 | 
    | A Dimeric Peptide That Binds Selectively to Prostate-Specific Membrane Antigen and Inhibits its Enzymatic Activity | journal | September 2006 | 
    | Phase I Evaluation of J591 as a Vascular Targeting Agent in Progressive Solid Tumors | journal | May 2007 | 
    | 2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer | journal | December 2011 | 
    | An AlphaScreen™-Based High-Throughput Screen to Identify Inhibitors of Hsp90-Cochaperone Interaction | journal | March 2009 | 
    | Screening for Inhibitors of Low-Affinity Epigenetic Peptide-Protein Interactions: An AlphaScreen™-Based Assay for Antagonists of Methyl-Lysine Binding Proteins | journal | December 2009 | 
    | Indium-111–Capromab Pendetide Radioimmunoscintigraphy and Prognosis for Durable Biochemical Response to Salvage Radiation Therapy in Men After Failed Prostatectomy | journal | May 2003 | 
    | Monoclonal Antibody Therapy for Prostate Cancer: Finally a Reality? | journal | July 2004 | 
    | Phase I Trial of 177 Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer | journal | July 2005 | 
    | Applicability of biomarkers in the early diagnosis of prostate cancer | journal | July 2004 | 
    | A Modular Strategy to Prepare Multivalent Inhibitors of Prostate-Specific Membrane Antigen (PSMA) | journal | December 2011 | 
    | High-affinity Near-infrared Fluorescent Small-molecule Contrast Agents for In Vivo Imaging of Prostate-specific Membrane Antigen | journal | October 2005 | 
    | Sequential SPECT and Optical Imaging of Experimental Models of Prostate Cancer with a Dual Modality Inhibitor of the Prostate-Specific Membrane Antigen | journal | August 2011 | 
    | Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer | journal | January 2004 | 
    | Radiotracer II: Peptide-Based Radiopharmaceuticals | book | January 2011 | 
    | [1] Affinity maturation of phage-displayed peptide ligands | book | January 1996 | 
    | 68 Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer | journal | July 2010 | 
    | Synthesis and Evaluation of Technetium-99m- and Rhenium-Labeled Inhibitors of the Prostate-Specific Membrane Antigen (PSMA) | journal | July 2008 | 
    | Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | journal | May 2004 | 
    | A homogeneous method for investigation of methylation-dependent protein-protein interactions in epigenetics | journal | November 2009 | 
    | A Dimeric Peptide That Binds Selectively to Prostate-Specific Membrane Antigen and Inhibits its Enzymatic Activity | journal | September 2006 | 
    | Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer | journal | August 2009 | 
    | Pilot Trial of Unlabeled and Indium-111–Labeled Anti–Prostate-Specific Membrane Antigen Antibody J591 for Castrate Metastatic Prostate Cancer | journal | October 2005 | 
    | Phase I Evaluation of J591 as a Vascular Targeting Agent in Progressive Solid Tumors | journal | May 2007 | 
    | 2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer | journal | December 2011 | 
    | Disulfide-constrained peptides that bind to the extracellular portion of the prostate-specific membrane antigen | journal | May 2004 | 
    | Synthesis and characterization of a high-affinity  v 6-specific ligand for in vitro and in vivo applications | journal | May 2009 | 
    | Phase I Trial of Yttrium-90—Labeled Anti—Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Androgen-Independent Prostate Cancer | journal | July 2004 | 
    | The Prognostic Significance of Indium-111–Capromab Penetide | journal | January 2004 | 
    | Phase I Trial of 177 Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer | journal | July 2005 | 
    | Screening for Prostate Cancer With Prostate-Specific Antigen Testing: American Society of Clinical Oncology Provisional Clinical Opinion | journal | August 2012 | 
    | Prostate-Specific Antigen Test for Prostate Cancer Screening: American Society of Clinical Oncology Provisional Clinical Opinion | journal | September 2012 | 
    | Discovery of High-Affinity Protein Binding Ligands – Backwards | journal | May 2010 | 
    | In Vivo Selection of Phage for the Optical Imaging of PC-3 Human Prostate Carcinoma in Mice | journal | September 2006 |